false
OasisLMS
Catalog
SCCM Resource Library
HAP and VAP in 2023
HAP and VAP in 2023
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this presentation, the speaker discusses hospital-acquired bacterial pneumonia (HAP) and ventilator-associated bacterial pneumonia (VAP). The speaker highlights the high incidence of suspected or proven infections among ICU patients, with pneumonia being a common site of infection. The presentation emphasizes the importance of rapid diagnostics for accurate and timely diagnosis of HAP and VAP. The speaker introduces two pneumonia panels that can provide instant results compared to traditional culture methods. The benefits of using rapid diagnostic panels include increased sensitivity, improved accuracy, and the ability to guide antibiotic decision making. The speaker also discusses new antibiotics approved for HAP and VAP treatment and the potential for updated clinical practice guidelines. The presentation concludes with the exploration of adjunctive inhaled antibiotics, treatment duration recommendations, biomarkers (such as procalcitonin) to support antibiotic decision making, and the importance of de-escalation in antimicrobial stewardship.
Asset Subtitle
Pulmonary, 2023
Asset Caption
Type: two-hour concurrent | Updates on Infectious Disease Guidelines in Critical Care (SessionID 1229708)
Meta Tag
Content Type
Presentation
Knowledge Area
Pulmonary
Membership Level
Professional
Membership Level
Select
Tag
Pneumonia
Tag
Ventilator Associated Pneumonia VAP
Year
2023
Keywords
hospital-acquired bacterial pneumonia
ventilator-associated bacterial pneumonia
rapid diagnostics
pneumonia panels
antibiotic decision making
antimicrobial stewardship
×
Please select your language
1
English